Serratus Plane Block for Postoperative Pain Control
Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blinded, placebo-controlled trial of serratus plane blocks in
subjects undergoing outpatient unilateral or bilateral breast surgery. Ninety subjects will
be enrolled into the study at presurgical testing. Subjects will be stratified based on
surgery type and randomized to receive a serratus plane block with either bupivicaine HCL or
placebo. All patients will receive standard intraoperative anesthesia and standard
postoperative pain control. The primary endpoint is the amount of opioid administered
postoperatively. Secondary endpoints include postoperative pain intensity at timed intervals,
amount of opioid administered intraoperatively and postoperatively, incidence of nausea and
vomiting, time to discharge and patient satisfaction